Stay updated on Omalizumab in Multi-Allergen OIT Clinical Trial

Sign up to get notified when there's something new on the Omalizumab in Multi-Allergen OIT Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Omalizumab in Multi-Allergen OIT Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The webpage has added helpful links provided by the National Institute of Allergy and Infectious Diseases (NIAID), which may enhance the resourcefulness of the page.
    Difference
    0.1%
    Check dated 2025-03-11T04:15:32.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.2%
    Check dated 2025-02-24T20:25:59.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    0.2%
    Check dated 2025-02-10T09:35:08.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    New data has been added regarding the proportion of participants able to consume various amounts of food protein without dose-limiting symptoms during double-blind placebo-controlled oral food challenges, particularly after treatment with omalizumab and omalizumab-facilitated oral immunotherapy, while previous updates and specific data points have been removed.
    Difference
    5%
    Check dated 2025-02-03T05:56:47.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.0%
    Check dated 2025-01-19T20:24:14.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this functionality.
    Difference
    0.0%
    Check dated 2025-01-12T17:04:39.000Z thumbnail image

Stay in the know with updates to Omalizumab in Multi-Allergen OIT Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Omalizumab in Multi-Allergen OIT Clinical Trial page.